nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—Hepatitis C—Lamivudine—hepatitis B	0.0498	0.0507	CcSEcCtD
Deferiprone—Multi-organ failure—Telbivudine—hepatitis B	0.047	0.0478	CcSEcCtD
Deferiprone—Myositis—Telbivudine—hepatitis B	0.0312	0.0318	CcSEcCtD
Deferiprone—Hepatomegaly—Entecavir—hepatitis B	0.0264	0.0268	CcSEcCtD
Deferiprone—Glycosuria—Entecavir—hepatitis B	0.023	0.0234	CcSEcCtD
Deferiprone—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.0225	0.0229	CcSEcCtD
Deferiprone—Hepatomegaly—Telbivudine—hepatitis B	0.0216	0.022	CcSEcCtD
Deferiprone—Sepsis—Telbivudine—hepatitis B	0.0133	0.0135	CcSEcCtD
Deferiprone—Hepatomegaly—Lamivudine—hepatitis B	0.0122	0.0124	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0117	0.0119	CcSEcCtD
Deferiprone—Pancreatitis—Entecavir—hepatitis B	0.0115	0.0117	CcSEcCtD
Deferiprone—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.0112	0.0114	CcSEcCtD
Deferiprone—Pain in extremity—Telbivudine—hepatitis B	0.0111	0.0113	CcSEcCtD
Deferiprone—Neutropenia—Entecavir—hepatitis B	0.0109	0.0111	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.01	0.0102	CcSEcCtD
Deferiprone—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00992	0.0101	CcSEcCtD
Deferiprone—Hepatobiliary disease—Entecavir—hepatitis B	0.00987	0.01	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00981	0.00998	CcSEcCtD
Deferiprone—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00963	0.0098	CcSEcCtD
Deferiprone—Rectal haemorrhage—Lamivudine—hepatitis B	0.00956	0.00973	CcSEcCtD
Deferiprone—Hepatitis—Entecavir—hepatitis B	0.00937	0.00953	CcSEcCtD
Deferiprone—Oedema peripheral—Entecavir—hepatitis B	0.00923	0.00939	CcSEcCtD
Deferiprone—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00914	0.0093	CcSEcCtD
Deferiprone—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00907	0.00923	CcSEcCtD
Deferiprone—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00903	0.00918	CcSEcCtD
Deferiprone—Neutropenia—Telbivudine—hepatitis B	0.00899	0.00915	CcSEcCtD
Deferiprone—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00898	0.00914	CcSEcCtD
Deferiprone—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00896	0.00912	CcSEcCtD
Deferiprone—Immune system disorder—Entecavir—hepatitis B	0.00846	0.00861	CcSEcCtD
Deferiprone—Mental disorder—Entecavir—hepatitis B	0.00821	0.00835	CcSEcCtD
Deferiprone—Malnutrition—Entecavir—hepatitis B	0.00815	0.0083	CcSEcCtD
Deferiprone—Hepatobiliary disease—Telbivudine—hepatitis B	0.00811	0.00825	CcSEcCtD
Deferiprone—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00796	0.0081	CcSEcCtD
Deferiprone—Back pain—Adefovir Dipivoxil—hepatitis B	0.0077	0.00783	CcSEcCtD
Deferiprone—Hepatitis—Telbivudine—hepatitis B	0.00769	0.00783	CcSEcCtD
Deferiprone—Pharyngitis—Telbivudine—hepatitis B	0.00764	0.00777	CcSEcCtD
Deferiprone—Connective tissue disorder—Telbivudine—hepatitis B	0.00756	0.0077	CcSEcCtD
Deferiprone—Sepsis—Lamivudine—hepatitis B	0.00749	0.00763	CcSEcCtD
Deferiprone—Mediastinal disorder—Telbivudine—hepatitis B	0.00694	0.00706	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00689	0.00702	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00673	0.00685	CcSEcCtD
Deferiprone—Malnutrition—Telbivudine—hepatitis B	0.0067	0.00682	CcSEcCtD
Deferiprone—Anaphylactic shock—Entecavir—hepatitis B	0.00665	0.00677	CcSEcCtD
Deferiprone—Infection—Entecavir—hepatitis B	0.00661	0.00673	CcSEcCtD
Deferiprone—Nervous system disorder—Entecavir—hepatitis B	0.00653	0.00664	CcSEcCtD
Deferiprone—Back pain—Telbivudine—hepatitis B	0.00648	0.00659	CcSEcCtD
Deferiprone—Skin disorder—Entecavir—hepatitis B	0.00646	0.00658	CcSEcCtD
Deferiprone—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00637	0.00648	CcSEcCtD
Deferiprone—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00631	0.00642	CcSEcCtD
Deferiprone—Somnolence—Entecavir—hepatitis B	0.00592	0.00602	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00592	0.00602	CcSEcCtD
Deferiprone—Dyspepsia—Entecavir—hepatitis B	0.00586	0.00596	CcSEcCtD
Deferiprone—Dehydration—Lamivudine—hepatitis B	0.00583	0.00593	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Entecavir—hepatitis B	0.00575	0.00585	CcSEcCtD
Deferiprone—Fatigue—Entecavir—hepatitis B	0.00574	0.00584	CcSEcCtD
Deferiprone—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00572	0.00582	CcSEcCtD
Deferiprone—Arthralgia—Telbivudine—hepatitis B	0.0057	0.0058	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00566	0.00576	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00564	0.00574	CcSEcCtD
Deferiprone—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00564	0.00574	CcSEcCtD
Deferiprone—Discomfort—Telbivudine—hepatitis B	0.00563	0.00573	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00561	0.0057	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00553	0.00563	CcSEcCtD
Deferiprone—Gastrointestinal pain—Entecavir—hepatitis B	0.00544	0.00554	CcSEcCtD
Deferiprone—Nervous system disorder—Telbivudine—hepatitis B	0.00536	0.00546	CcSEcCtD
Deferiprone—Pancreatitis—Lamivudine—hepatitis B	0.00531	0.00541	CcSEcCtD
Deferiprone—Skin disorder—Telbivudine—hepatitis B	0.00531	0.0054	CcSEcCtD
Deferiprone—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00531	0.0054	CcSEcCtD
Deferiprone—Body temperature increased—Entecavir—hepatitis B	0.00526	0.00535	CcSEcCtD
Deferiprone—Abdominal pain—Entecavir—hepatitis B	0.00526	0.00535	CcSEcCtD
Deferiprone—Pancytopenia—Lamivudine—hepatitis B	0.00515	0.00524	CcSEcCtD
Deferiprone—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00513	0.00522	CcSEcCtD
Deferiprone—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00513	0.00522	CcSEcCtD
Deferiprone—Neutropenia—Lamivudine—hepatitis B	0.00507	0.00516	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00498	0.00507	CcSEcCtD
Deferiprone—Dyspepsia—Telbivudine—hepatitis B	0.00481	0.0049	CcSEcCtD
Deferiprone—Asthenia—Entecavir—hepatitis B	0.00477	0.00486	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00472	0.0048	CcSEcCtD
Deferiprone—Fatigue—Telbivudine—hepatitis B	0.00471	0.0048	CcSEcCtD
Deferiprone—Jaundice—Lamivudine—hepatitis B	0.00471	0.00479	CcSEcCtD
Deferiprone—Pain—Telbivudine—hepatitis B	0.00468	0.00476	CcSEcCtD
Deferiprone—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00466	0.00474	CcSEcCtD
Deferiprone—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00459	0.00467	CcSEcCtD
Deferiprone—Hepatobiliary disease—Lamivudine—hepatitis B	0.00457	0.00465	CcSEcCtD
Deferiprone—Epistaxis—Lamivudine—hepatitis B	0.00456	0.00464	CcSEcCtD
Deferiprone—Diarrhoea—Entecavir—hepatitis B	0.00455	0.00463	CcSEcCtD
Deferiprone—Agranulocytosis—Lamivudine—hepatitis B	0.00451	0.00459	CcSEcCtD
Deferiprone—Gastrointestinal pain—Telbivudine—hepatitis B	0.00447	0.00455	CcSEcCtD
Deferiprone—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00444	0.00452	CcSEcCtD
Deferiprone—Hepatitis—Lamivudine—hepatitis B	0.00434	0.00441	CcSEcCtD
Deferiprone—Body temperature increased—Telbivudine—hepatitis B	0.00432	0.0044	CcSEcCtD
Deferiprone—Abdominal pain—Telbivudine—hepatitis B	0.00432	0.0044	CcSEcCtD
Deferiprone—Pharyngitis—Lamivudine—hepatitis B	0.0043	0.00438	CcSEcCtD
Deferiprone—Connective tissue disorder—Lamivudine—hepatitis B	0.00426	0.00434	CcSEcCtD
Deferiprone—Vomiting—Entecavir—hepatitis B	0.00423	0.00431	CcSEcCtD
Deferiprone—Rash—Entecavir—hepatitis B	0.0042	0.00427	CcSEcCtD
Deferiprone—Dermatitis—Entecavir—hepatitis B	0.00419	0.00427	CcSEcCtD
Deferiprone—Headache—Entecavir—hepatitis B	0.00417	0.00424	CcSEcCtD
Deferiprone—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00413	0.0042	CcSEcCtD
Deferiprone—Rash—Adefovir Dipivoxil—hepatitis B	0.00409	0.00417	CcSEcCtD
Deferiprone—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00409	0.00416	CcSEcCtD
Deferiprone—Headache—Adefovir Dipivoxil—hepatitis B	0.00407	0.00414	CcSEcCtD
Deferiprone—Nausea—Entecavir—hepatitis B	0.00395	0.00402	CcSEcCtD
Deferiprone—Asthenia—Telbivudine—hepatitis B	0.00392	0.00399	CcSEcCtD
Deferiprone—Immune system disorder—Lamivudine—hepatitis B	0.00392	0.00399	CcSEcCtD
Deferiprone—Mediastinal disorder—Lamivudine—hepatitis B	0.00391	0.00398	CcSEcCtD
Deferiprone—Chills—Lamivudine—hepatitis B	0.00389	0.00396	CcSEcCtD
Deferiprone—Pruritus—Telbivudine—hepatitis B	0.00387	0.00394	CcSEcCtD
Deferiprone—Nausea—Adefovir Dipivoxil—hepatitis B	0.00386	0.00392	CcSEcCtD
Deferiprone—Malnutrition—Lamivudine—hepatitis B	0.00378	0.00384	CcSEcCtD
Deferiprone—Diarrhoea—Telbivudine—hepatitis B	0.00374	0.00381	CcSEcCtD
Deferiprone—Back pain—Lamivudine—hepatitis B	0.00365	0.00372	CcSEcCtD
Deferiprone—Vomiting—Telbivudine—hepatitis B	0.00348	0.00354	CcSEcCtD
Deferiprone—Rash—Telbivudine—hepatitis B	0.00345	0.00351	CcSEcCtD
Deferiprone—Dermatitis—Telbivudine—hepatitis B	0.00344	0.0035	CcSEcCtD
Deferiprone—Headache—Telbivudine—hepatitis B	0.00342	0.00349	CcSEcCtD
Deferiprone—Convulsion—Lamivudine—hepatitis B	0.00327	0.00333	CcSEcCtD
Deferiprone—Nausea—Telbivudine—hepatitis B	0.00325	0.0033	CcSEcCtD
Deferiprone—Arthralgia—Lamivudine—hepatitis B	0.00321	0.00327	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00319	0.00325	CcSEcCtD
Deferiprone—Discomfort—Lamivudine—hepatitis B	0.00318	0.00323	CcSEcCtD
Deferiprone—Anaphylactic shock—Lamivudine—hepatitis B	0.00308	0.00314	CcSEcCtD
Deferiprone—Infection—Lamivudine—hepatitis B	0.00306	0.00311	CcSEcCtD
Deferiprone—Nervous system disorder—Lamivudine—hepatitis B	0.00302	0.00307	CcSEcCtD
Deferiprone—Skin disorder—Lamivudine—hepatitis B	0.00299	0.00305	CcSEcCtD
Deferiprone—Hyperhidrosis—Lamivudine—hepatitis B	0.00298	0.00303	CcSEcCtD
Deferiprone—Hypotension—Lamivudine—hepatitis B	0.00288	0.00293	CcSEcCtD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00284	0.164	CbGpPWpGaD
Deferiprone—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00281	0.00286	CcSEcCtD
Deferiprone—Somnolence—Lamivudine—hepatitis B	0.00274	0.00279	CcSEcCtD
Deferiprone—Dyspepsia—Lamivudine—hepatitis B	0.00271	0.00276	CcSEcCtD
Deferiprone—Decreased appetite—Lamivudine—hepatitis B	0.00268	0.00273	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00266	0.00271	CcSEcCtD
Deferiprone—Fatigue—Lamivudine—hepatitis B	0.00266	0.0027	CcSEcCtD
Deferiprone—Pain—Lamivudine—hepatitis B	0.00263	0.00268	CcSEcCtD
Deferiprone—Gastrointestinal pain—Lamivudine—hepatitis B	0.00252	0.00256	CcSEcCtD
Deferiprone—Urticaria—Lamivudine—hepatitis B	0.00245	0.00249	CcSEcCtD
Deferiprone—Abdominal pain—Lamivudine—hepatitis B	0.00244	0.00248	CcSEcCtD
Deferiprone—Body temperature increased—Lamivudine—hepatitis B	0.00244	0.00248	CcSEcCtD
Deferiprone—Hypersensitivity—Lamivudine—hepatitis B	0.00227	0.00231	CcSEcCtD
Deferiprone—Asthenia—Lamivudine—hepatitis B	0.00221	0.00225	CcSEcCtD
Deferiprone—Pruritus—Lamivudine—hepatitis B	0.00218	0.00222	CcSEcCtD
Deferiprone—Diarrhoea—Lamivudine—hepatitis B	0.00211	0.00215	CcSEcCtD
Deferiprone—UGT1A6—Phase II conjugation—GGT2—hepatitis B	0.00209	0.12	CbGpPWpGaD
Deferiprone—Vomiting—Lamivudine—hepatitis B	0.00196	0.00199	CcSEcCtD
Deferiprone—Rash—Lamivudine—hepatitis B	0.00194	0.00198	CcSEcCtD
Deferiprone—Dermatitis—Lamivudine—hepatitis B	0.00194	0.00198	CcSEcCtD
Deferiprone—Headache—Lamivudine—hepatitis B	0.00193	0.00196	CcSEcCtD
Deferiprone—Nausea—Lamivudine—hepatitis B	0.00183	0.00186	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—GGT2—hepatitis B	0.00139	0.0803	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—AKR1B1—hepatitis B	0.00126	0.0725	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GGT2—hepatitis B	0.00122	0.0705	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GGT1—hepatitis B	0.000988	0.057	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—NFKB1—hepatitis B	0.000944	0.0544	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—CYP2A6—hepatitis B	0.000844	0.0487	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000806	0.0465	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP2A6—hepatitis B	0.000741	0.0427	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000716	0.0413	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GGT1—hepatitis B	0.000659	0.038	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GGT1—hepatitis B	0.000578	0.0333	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000559	0.0322	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000522	0.0301	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—TGFB1—hepatitis B	0.000222	0.0128	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—AKR1B1—hepatitis B	0.000218	0.0126	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GGT2—hepatitis B	0.000209	0.0121	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP2A6—hepatitis B	0.000127	0.0073	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GOT2—hepatitis B	0.000115	0.0066	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GOT1—hepatitis B	9.89e-05	0.0057	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GGT1—hepatitis B	9.89e-05	0.0057	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ALB—hepatitis B	5.26e-05	0.00303	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PTEN—hepatitis B	4.01e-05	0.00231	CbGpPWpGaD
